Ayoub

Ayub Lab, also known as Ayub Research, is a biotechnology research entity focused on discovering and developing therapeutic compounds from natural plant sources, particularly Boswellia sacra (frankincense). Founded in 2006, the organization conducts interdisciplinary research spanning plant biology, biochemistry, and pharmacology to identify anti-malignant and anti-inflammatory properties in botanical extracts. Its core work, the Ayub S42 project, investigates the efficacy of frankincense-derived fractions against various cancers, while other programs like Imucure and Arurax target autoimmune and skin conditions. The lab operates as an independent, collaborative research program with a presence in Oman and the United States.